Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.

NCT00440817

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +19 more
Locations: Highland Park, Illinois, United States

Wichita, Kansas, United States

Albany, New York, United States

View Trial Details

Completed

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

NCT00724984

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations: University of California, San Francisco San Francisco, California, United States

Northwestern University Medical School Chicago, Illinois, United States

Horizon Oncology Center Lafayette, Indiana, United States

University of Massachusetts Medical School Worcester, Massachusetts, United States

View Trial Details

Completed

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00033332

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States

Stanford University Medical Center Stanford, California, United States

View all 78 locations

View Trial Details

Completed

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

NCT00847639

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: City of Hope National Medical Center Duarte, California, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

University of Minnesota Medical Center Minneapolis, Minnesota, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

NCT01246557

Conditions: Chronic Disease, Chronic Lymphatic Leukemia, Disease Attributes, +14 more
Locations: Centro Médico Teknon Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital Universitari Valle Hebron Barcelona, Spain

Hospital Clinico Universitario de Barcelona Barcelona, Spain

View Trial Details

Completed

CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

NCT00033267

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis

NCT01072773

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations: Stanford University School of Medicine Stanford, California, United States

New York Presbyterian Hosptial Cornell Med Center New York, United States

The Ohio State University Columbus, Ohio, United States

Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States

View Trial Details

Completed

Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma

NCT02099292

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details